InvestorsHub Logo
Followers 17
Posts 1064
Boards Moderated 0
Alias Born 07/20/2010

Re: None

Thursday, 06/29/2023 3:04:18 PM

Thursday, June 29, 2023 3:04:18 PM

Post# of 36602
Bullish case from Hattrick on Stocktwits

Hattrick3
16m
@Dirtymartini66 as frustrating as it’s been, this is far from over. No solutions are available, the Covid Therapeutic revenue projections are well over $30 billion in a few short years. Piles of money to be made. Start connecting the dots, the “sister” company Pharma Ther has just signed an agreement with Virtruvias Therapeutics out of Alabama. They have a CEO who has been in the business for decades and their Director worked for Johnson and Johnson for decades. They are also experts in the generic space. Phrrf is down the hall from Revive and they own a large chunk of Revive shares, enough to pay for their Ketarx trial when it launches if Revive can do something with Buci. Way too much money to be made and a drug that by every measurement has worked in every study that’s been done to date; trial data is coming. Is it possible that it doesn’t go any further; yep! Just not probable with the $$$ on the table for the company that has a Covid therapeutic; the drug works.
Bullish